P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy

Benzer Materyaller

• Optimization of dose and route of administration of the P‐glycoprotein inhibitor, valspodar (PSC‐833) and the P‐glycoprotein and breast cancer resistance protein dual‐inhibitor, elacridar (GF120918) as dual infusion in rats
  Yazar:: Christopher Rowbottom, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-04-01)
• Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
  Yazar:: Sparreboom, Alex, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy
  Yazar:: Sankatsing, Sanjay U. C., ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
  Yazar:: Schinkel, A H, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.
  Yazar:: Schinkel, A H, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)